Paper12023402
Characterization of CD4(+) CTLs ex vivo.
Appay V and 12 others. J Immunol, 2002. Cited by 457 papers, by iCite.
Cite this record
ConductScience Library. Characterization of CD4(+) CTLs ex vivo. Papers, record 12023402. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12023402
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD4 Antigens | Major topic |
| T-Lymphocytes, Cytotoxic | Major topic |
| CD8-Positive T-Lymphocytes | |
| Chronic Disease | |
| HIV Infections | |
| Humans | |
| Membrane Glycoproteins | |
| Perforin | |
| Pore Forming Cytotoxic Proteins |
Source PubMed
Cited by261
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 457 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42261594 | Identifying Negative Biomarkers of CD4 Cytotoxic T Lymphocytes via Granzyme B Exclusion Analysis. | Eur J Immunol | 2026 | https://conductscience.org/library/papers/42261594 | PubMed |
| 42025535 | Development of a pediatric immune cell atlas and characterization of CD4+ T cells in food allergy. | Pediatr Allergy Immunol | 2026 | https://conductscience.org/library/papers/42025535 | PubMed |
| 41871309 | Cytomegalovirus Drives the Development of Cytotoxic CD4+ T Cells in Patients With Multiple Sclerosis. | Neurol Neuroimmunol Neuroinflamm | 2026 | https://conductscience.org/library/papers/41871309 | PubMed |
| 41853277 | Distinct landscapes of T-cell immunity and TCR repertoire between sepsis and pre-septic high-risk states. | Front Immunol | 2026 | https://conductscience.org/library/papers/41853277 | PubMed |
| 41803090 | Cytotoxic CD4+ T cells: origin, biological functions, diseases and therapeutic targets. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/41803090 | PubMed |
| 41697467 | Cytotoxic CD4 T Cells: Dual Agents in HIV-1 Pathogenesis and Persistence. | Curr HIV/AIDS Rep | 2026 | https://conductscience.org/library/papers/41697467 | PubMed |
| 41437267 | Cytotoxic T lymphocytes and their dual role in modulating blood-brain barrier integrity in immune-mediated neurological pathologies. | J Transl Med | 2025 | https://conductscience.org/library/papers/41437267 | PubMed |
| 41436233 | Cytotoxic CD4+ T cells in cancer: an emerging target for next-generation anticancer immunotherapy? | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/41436233 | PubMed |
| 41091129 | FCRL3 is an immunoregulatory receptor that restrains the activation of human memory T lymphocytes. | J Exp Med | 2026 | https://conductscience.org/library/papers/41091129 | PubMed |
| 41034205 | Long-persisting SARS-CoV-2 spike-specific CD4+ T cells associated with mild disease and increased cytotoxicity post COVID-19. | Nat Commun | 2025 | https://conductscience.org/library/papers/41034205 | PubMed |
| 40939292 | TIM-3 ameliorates host responses to Salmonella infection by controlling iron driven CD4+ T cell differentiation and interleukin-10 formation. | EBioMedicine | 2025 | https://conductscience.org/library/papers/40939292 | PubMed |
| 40438110 | Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations. | Front Immunol | 2025 | https://conductscience.org/library/papers/40438110 | PubMed |
| 40430784 | The Epithelial Immune Response to Human Papillomavirus Infection. | Pathogens | 2025 | https://conductscience.org/library/papers/40430784 | PubMed |
| 40214640 | Plasmodium falciparum infection induces T cell tolerance that is associated with decreased disease severity upon re-infection. | J Exp Med | 2025 | https://conductscience.org/library/papers/40214640 | PubMed |
| 40070836 | Co-expression of B7-H3 and LAG3 represents cytotoxicity of CD4+ T cells in humans. | Front Immunol | 2025 | https://conductscience.org/library/papers/40070836 | PubMed |
| 40038305 | Blood and tissue HIV-1 reservoirs display plasticity and lack of compartmentalization in virally suppressed people. | Nat Commun | 2025 | https://conductscience.org/library/papers/40038305 | PubMed |
| 40035468 | Cytotoxic Signature and IFN-γ Production Dominate CD4+ T-Cell Response During Human Toxoplasmosis. | Immunology | 2025 | https://conductscience.org/library/papers/40035468 | PubMed |
| 39239709 | Implications of accumulation of clonally expanded and senescent CD4+GNLY+ T cells in immunological non-responders of HIV-1 infection. | Emerg Microbes Infect | 2024 | https://conductscience.org/library/papers/39239709 | PubMed |
| 39090138 | Recurrent fever of unknown origin and unexplained bacteremia in a patient with a novel 4.5 Mb microdeletion in Xp11.23-p11.22. | Sci Rep | 2024 | https://conductscience.org/library/papers/39090138 | PubMed |
| 39062756 | The Complex Dysregulations of CD4 T Cell Subtypes in HIV Infection. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39062756 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12023402
GET https://conductscience.org/api/papers/v1/12023402/cited_by?page=2